DRUG·10919W405·US·equity·Healthcare - Biotechnology-13D/G
DRUG (Bright Minds Biosciences Inc.) is held by 49 institutional investors as of Q4 2025. Largest holders: JANUS HENDERSON GROUP PLC ($90.8M), ADAGE CAPITAL PARTNERS GP, L.L.C. ($30.9M), BlackRock, Inc. ($30.8M). Net institutional sentiment: Mixed.
See how DRUG's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer